Kothari Ferment.

Who are the top shareholders of the Kothari Ferment.?

The top shareholders of Kothari Ferment include Siddhant Kothari with 24.85%, individual investors with 25.93%, and the highest public shareholder, Dheeraj Kumar Lohia, at 1.47%. There are no mutual funds or foreign institutional investors involved.

The top shareholders of Kothari Ferment include the promoters, with Siddhant Kothari holding the highest stake at 24.85%. Individual investors collectively hold 25.93% of the shares. The highest public shareholder is Dheeraj Kumar Lohia, who owns 1.47% of the company. Notably, there are no mutual funds or foreign institutional investors holding shares in the company.

Who are in the management team of Kothari Ferment.?

As of March 2022, the management team of Kothari Ferment includes Pramod Kumar Kothari (Chairman & Managing Director), Kavita Devi Kothari (Whole-time Director), Siddhant Kothari (Whole-time Director), and several independent directors: Hemedra Pat Singh Dugar, Piyush Kumar Goel, and Rajiv Agarwal, along with Silky Gupta as Company Secretary & Compliance Officer.

As of March 2022, the management team of Kothari Ferment includes the following members:<BR><BR>1. Pramod Kumar Kothari - Chairman & Managing Director<BR>2. Kavita Devi Kothari - Whole-time Director<BR>3. Hemedra Pat Singh Dugar - Independent Director<BR>4. Piyush Kumar Goel - Independent Director<BR>5. Siddhant Kothari - Whole-time Director<BR>6. Silky Gupta - Company Secretary & Compliance Officer<BR>7. Rajiv Agarwal - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

What does Kothari Ferment. do?

Kothari Fermentation & Biochem Ltd manufactures yeast and its derivatives in the FMCG sector. As of March 2025, it reported net sales of ₹32 Cr and a net profit of ₹1 Cr, with a market cap of ₹106 Cr.

Overview:<BR>Kothari Fermentation & Biochem Ltd is a manufacturer of yeast and its derivatives, operating in the FMCG industry within the micro-cap market segment.<BR><BR>History:<BR>Incorporated in 1990, Kothari Fermentation and Biochem Ltd (KFBL) was promoted by Motilal Kothari and his Associates. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 32 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 1 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 106 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 109.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.77 <BR>Return on Equity: 1.47% <BR>Price to Book: 1.97 <BR><BR>Contact Details:<BR>Address: 16 Community Centre, 1st Floor Saket New Delhi New Delhi : 110017 <BR>Tel: 91-011-26517665/26850004/40590944 <BR>Email: info@kothariyeast.in <BR>Website: http://www.kothariyeast.in

Has Kothari Ferment. declared dividend?

No Dividend History Available

Who are the peers of the Kothari Ferment.?

Kothari Ferment's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Terai Tea Co, Palash Securi., Tanvi Foods, Omfurn India, and Grob Tea Co. Kothari Ferment has below-average management risk and capital structure, with a 1-year return of 7.15%.

Peers: The peers of Kothari Ferment are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Terai Tea Co, Palash Securi., Tanvi Foods, Omfurn India, and Grob Tea Co.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer. Below Average management risk is noted for Terai Tea Co, Palash Securi., Kothari Ferment., Tanvi Foods, Omfurn India, and Grob Tea Co. Growth is Average at Nestle India, while Below Average growth is seen at Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Terai Tea Co, Palash Securi., Kothari Ferment., Tanvi Foods, Omfurn India, and Grob Tea Co. Excellent capital structure is present at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, and Palash Securi., while Below Average capital structure is noted for Terai Tea Co, Kothari Ferment., Tanvi Foods, Omfurn India, and Grob Tea Co.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Terai Tea Co at 108.38%, while the lowest is Tanvi Foods at -53.58%. Kothari Ferment's 1-year return is 7.15%, which is significantly higher than Tanvi Foods but lower than Terai Tea Co. Additionally, the six-month return is negative for Palash Securi., Tanvi Foods, and Omfurn India.

What is the technical trend for Kothari Ferment.?

As of June 2, 2025, Kothari Ferment's technical trend is mildly bearish, influenced by bearish daily moving averages and a mildly bearish monthly MACD, despite some bullish indicators on the weekly charts.

As of 2 June 2025, the technical trend for Kothari Ferment has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD indicates a mildly bearish stance. Moving averages on the daily time frame are bearish, and the Bollinger Bands show a bearish trend on the monthly chart. The KST is bullish on the weekly but mildly bearish on the monthly, while Dow Theory presents a mildly bearish outlook on the weekly and mildly bullish on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the bearish daily moving averages and the monthly MACD.

How big is Kothari Ferment.?

As of 24th July, Kothari Fermentation & Biochem Ltd has a market capitalization of 102.00 Cr, with net sales of 114.24 Cr and a net profit of 0.81 Cr for the latest four quarters. The company has shareholder's funds of 55.91 Cr and total assets of 132.13 Cr as of March 2024.

As of 24th July, Kothari Fermentation & Biochem Ltd has a market capitalization of 102.00 Cr, which classifies it as a Micro Cap company.<BR><BR>In the latest four quarters, Kothari Fermentation reported Net Sales of 114.24 Cr and a Net Profit of 0.81 Cr.<BR><BR>For the latest annual period ending in March 2024, the company has Shareholder's Funds amounting to 55.91 Cr and Total Assets of 132.13 Cr.

How has been the historical performance of Kothari Ferment.?

Kothari Ferment's historical performance shows a recovery in Mar'25, with net sales rising to 114.23 Cr and operating profit improving to 11.87 Cr, compared to previous losses. Total assets and liabilities decreased, while cash flow from operations increased to 10.00 Cr.

Answer:<BR>The historical performance of Kothari Ferment shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Kothari Ferment's net sales increased from 108.88 Cr in Mar'24 to 114.23 Cr in Mar'25, following a dip in Mar'23. Total operating income also rose to 114.23 Cr in Mar'25 from 108.88 Cr in the previous year. However, the total expenditure decreased slightly from 103.73 Cr in Mar'24 to 102.36 Cr in Mar'25. Operating profit, excluding other income, improved significantly to 11.87 Cr in Mar'25 from 5.15 Cr in Mar'24, while profit before tax turned positive at 1.94 Cr after a loss of 3.93 Cr in the prior year. Profit after tax also recovered to 0.81 Cr in Mar'25 from a loss of 4.91 Cr in Mar'24. The company's total assets decreased from 132.13 Cr in Mar'24 to 127.92 Cr in Mar'25, and total liabilities also fell from 132.13 Cr to 127.92 Cr during the same period. Cash flow from operating activities showed an increase to 10.00 Cr in Mar'25 from 8.00 Cr in Mar'24, while cash flow from investing activities improved as well, reflecting a less negative outflow. Overall, Kothari Ferment's financial performance in Mar'25 indicates a recovery from previous losses, with improvements in sales, profits, and cash flow.

Is Kothari Ferment. overvalued or undervalued?

As of December 2, 2025, Kothari Ferment. is considered overvalued with a PE ratio of -24.53 and an EV to EBITDA of 12.35, showing poor performance with a 43.93% decline in stock price compared to the Sensex's 6.09% increase, despite having a lower PE ratio than peers like Hindustan Unilever and Nestle India.

As of 2 December 2025, Kothari Ferment. has moved from an attractive to a fair valuation grade. The company appears to be overvalued based on its current metrics. Key ratios include a PE ratio of -24.53, an EV to EBITDA of 12.35, and a ROCE of 2.23%. <BR><BR>In comparison to its peers, Kothari Ferment. stands out with a significantly lower PE ratio than Hindustan Unilever at 55.03 and Nestle India at 81.19, both of which are categorized as very expensive. Additionally, while Kothari's EV to EBITDA ratio is 12.35, it remains more favorable than many peers, yet the overall valuation suggests it does not justify its current price of 44.80, especially given its poor stock performance relative to the Sensex over the past year, where it has declined by 43.93% compared to the Sensex's 6.09% increase.

When is the next results date for Kothari Fermentation & Biochem Ltd?

The next results date for Kothari Fermentation & Biochem Ltd is 29 May 2026.

The next results date for Kothari Fermentation & Biochem Ltd is scheduled for 29 May 2026.

Which are the latest news on Kothari Ferment.?

Are Kothari Fermentation & Biochem Ltd latest results good or bad?

Kothari Fermentation & Biochem Ltd's latest results show a return to profitability with a net profit of ₹1.27 crore in Q4 FY26, but revenue growth is stagnant at just 0.90% year-on-year, raising concerns about the sustainability of this recovery amid high financial leverage and a significant stock price decline. Investors should approach with caution due to the company's fragile financial health.

Kothari Fermentation & Biochem Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹1.27 crore for Q4 FY26, a significant improvement from a loss of ₹0.38 crore in the previous quarter. This marks a positive turnaround in profitability after three consecutive quarters of losses. Additionally, the operating margin improved to 8.96%, up from 7.45% in the prior quarter.<BR><BR>However, the revenue growth remains concerning, with only a 0.90% increase year-on-year, indicating stagnation in sales. The company has faced significant challenges over the past year, reflected in a dramatic 46.70% decline in its stock price, which has underperformed the broader FMCG sector.<BR><BR>Overall, while the return to profitability in Q4 is a positive development, the underlying issues such as weak revenue growth, high financial leverage, and poor return on equity raise questions about the sustainability of this recovery. Investors should be cautious, as the company's financial health remains fragile and its future performance uncertain.

Should I buy, sell or hold Kothari Fermentation & Biochem Ltd?

Why is Kothari Fermentation & Biochem Ltd falling/rising?

As of 03-Jun, Kothari Fermentation & Biochem Ltd's stock price is declining, currently at 41.60, with a recent total return of -0.36%. The stock has mixed performance against the Sensex, showing a significant year-to-date decline of -4.37% and a concerning one-year drop of -45.64%, alongside reduced investor participation.

As of 03-Jun, Kothari Fermentation & Biochem Ltd's stock price is experiencing a slight decline, currently at 41.60, reflecting a change of -0.1 (-0.24%). This decrease follows a trend where the stock has been losing value for the past two days, resulting in a total return of -0.36% during this period. <BR><BR>In terms of performance relative to the benchmark, the stock has shown mixed results over various time frames. Over the past week, it has outperformed the Sensex with a gain of +1.41%, while over the past month, it has slightly underperformed with a decline of -0.17% compared to the Sensex's -3.34%. However, the year-to-date performance shows a more significant decline of -4.37% against the Sensex's -12.76%, and the one-year performance is particularly concerning, with a drop of -45.64% compared to the Sensex's -7.92%.<BR><BR>Additionally, investor participation appears to be waning, as evidenced by a significant drop in delivery volume, which fell by -55.62% against the 5-day average. This decline in trading activity may contribute to the stock's downward pressure. While the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below the 200-day moving average, indicating a longer-term bearish trend.<BR><BR>Overall, the combination of recent price declines, reduced investor participation, and poor long-term performance relative to the benchmark suggests that Kothari Fermentation & Biochem Ltd is currently facing downward pressure on its stock price.